Delving into the Latest Updates on LNF2008 with Synapse

Overview

Basic Info

Drug Type

Monoclonal antibody

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

Neoplasms

Active Indication

Advanced Malignant Solid Neoplasm

Inactive Indication-

Originator Organization

Shandong New Time Pharmaceutical Co. Ltd.

Active Organization

Shandong New Time Pharmaceutical Co. Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

主要研究目的：评估LNF2008在晚期实体瘤受试者中的安全性和耐受性；评估LNF2008在晚期实体瘤受试者中的剂量限制性毒性（DLT），确定最大耐受剂量（MTD）和/或Ⅱ期推荐剂量（RP2D）。次要研究目的：评估LNF2008在晚期实体瘤受试者中的药代动力学（PK）特征；评估LNF2008在晚期实体瘤受试者中的初步疗效；评估LNF2008在晚期实体瘤受试者中的免疫原性。

[Translation]

Primary study objectives: To evaluate the safety and tolerability of LNF2008 in subjects with advanced solid tumors; To evaluate the dose-limiting toxicity (DLT) of LNF2008 in subjects with advanced solid tumors, and to determine the maximum tolerated dose (MTD) and/or the recommended dose for Phase II (RP2D). Secondary study objectives: To evaluate the pharmacokinetic (PK) characteristics of LNF2008 in subjects with advanced solid tumors; To evaluate the preliminary efficacy of LNF2008 in subjects with advanced solid tumors; To evaluate the immunogenicity of LNF2008 in subjects with advanced solid tumors.

Start Date15 Aug 2024

Sponsor / Collaborator

Shandong New Time Pharmaceutical Co. Ltd.

100 Clinical Results associated with LNF2008

Login to view more data

100 Translational Medicine associated with LNF2008

Login to view more data

100 Patents (Medical) associated with LNF2008

Login to view more data

100 Deals associated with LNF2008

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Advanced Malignant Solid Neoplasm	Phase 1	China	Shandong New Time Pharmaceutical Co. Ltd.	15 Aug 2024

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data